Clinical Trial Update: Comparing Efficacy and Safety of Stivant (AryoGen Bevacizumab) Versus Avastin in Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Stivant (AryoGen bevacizumab) to Avastin in metastatic colorectal cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Stivant (bevacizumab)

Snippet

Sponsor: AryoGen Pharmed Co. | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2021-01-22